Facts and reflections on COVID-19 and anti-hypertensives drugs

Autores
Marín, Gustavo Horacio
Año de publicación
2020
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensive drug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin II receptor blockers (e.g. losartan), many patients from South America, Central America or Spain, have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominous consequences due to this drop out. For this reason, it is necessary to quickly warn about this situation and the risks associated with it.
Facultad de Ciencias Médicas
Consejo Nacional de Investigaciones Científicas y Técnicas
Materia
Ciencias Médicas
ACE
ATII-RB
Anti-hypertensive drugs
COVID-19
SARS-CoV-2
Nivel de accesibilidad
acceso abierto
Condiciones de uso
http://creativecommons.org/licenses/by-nc-sa/4.0/
Repositorio
SEDICI (UNLP)
Institución
Universidad Nacional de La Plata
OAI Identificador
oai:sedici.unlp.edu.ar:10915/124182
Acceder
id SEDICI_2f51908fea25796bb7e206b57745233c
oai_identifier_str oai:sedici.unlp.edu.ar:10915/124182
network_acronym_str SEDICI
repository_id_str 1329
network_name_str SEDICI (UNLP)
spelling Facts and reflections on COVID-19 and anti-hypertensives drugsMarín, Gustavo HoracioCiencias MédicasACEATII-RBAnti-hypertensive drugsCOVID-19SARS-CoV-2Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensive drug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin II receptor blockers (e.g. losartan), many patients from South America, Central America or Spain, have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominous consequences due to this drop out. For this reason, it is necessary to quickly warn about this situation and the risks associated with it.Facultad de Ciencias MédicasConsejo Nacional de Investigaciones Científicas y Técnicas2020-03-26info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArticulohttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdf105-106http://sedici.unlp.edu.ar/handle/10915/124182enginfo:eu-repo/semantics/altIdentifier/issn/1881-784Xinfo:eu-repo/semantics/altIdentifier/issn/1881-7831info:eu-repo/semantics/altIdentifier/pmid/32213760info:eu-repo/semantics/altIdentifier/doi/10.5582/ddt.2020.01017info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-sa/4.0/Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2025-09-29T11:29:33Zoai:sedici.unlp.edu.ar:10915/124182Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292025-09-29 11:29:33.617SEDICI (UNLP) - Universidad Nacional de La Platafalse
dc.title.none.fl_str_mv Facts and reflections on COVID-19 and anti-hypertensives drugs
title Facts and reflections on COVID-19 and anti-hypertensives drugs
spellingShingle Facts and reflections on COVID-19 and anti-hypertensives drugs
Marín, Gustavo Horacio
Ciencias Médicas
ACE
ATII-RB
Anti-hypertensive drugs
COVID-19
SARS-CoV-2
title_short Facts and reflections on COVID-19 and anti-hypertensives drugs
title_full Facts and reflections on COVID-19 and anti-hypertensives drugs
title_fullStr Facts and reflections on COVID-19 and anti-hypertensives drugs
title_full_unstemmed Facts and reflections on COVID-19 and anti-hypertensives drugs
title_sort Facts and reflections on COVID-19 and anti-hypertensives drugs
dc.creator.none.fl_str_mv Marín, Gustavo Horacio
author Marín, Gustavo Horacio
author_facet Marín, Gustavo Horacio
author_role author
dc.subject.none.fl_str_mv Ciencias Médicas
ACE
ATII-RB
Anti-hypertensive drugs
COVID-19
SARS-CoV-2
topic Ciencias Médicas
ACE
ATII-RB
Anti-hypertensive drugs
COVID-19
SARS-CoV-2
dc.description.none.fl_txt_mv Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensive drug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin II receptor blockers (e.g. losartan), many patients from South America, Central America or Spain, have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominous consequences due to this drop out. For this reason, it is necessary to quickly warn about this situation and the risks associated with it.
Facultad de Ciencias Médicas
Consejo Nacional de Investigaciones Científicas y Técnicas
description Based on some publications that associate SARS-CoV-2 infection with the use of anti-hypertensive drug groups such as angiotensin-converting-enzyme inhibitors (e.g. enalapril) or angiotensin II receptor blockers (e.g. losartan), many patients from South America, Central America or Spain, have stopped or intend to interrupt their treatments with these drugs. Hence, it may exist ominous consequences due to this drop out. For this reason, it is necessary to quickly warn about this situation and the risks associated with it.
publishDate 2020
dc.date.none.fl_str_mv 2020-03-26
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Articulo
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://sedici.unlp.edu.ar/handle/10915/124182
url http://sedici.unlp.edu.ar/handle/10915/124182
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/issn/1881-784X
info:eu-repo/semantics/altIdentifier/issn/1881-7831
info:eu-repo/semantics/altIdentifier/pmid/32213760
info:eu-repo/semantics/altIdentifier/doi/10.5582/ddt.2020.01017
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by-nc-sa/4.0/
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-sa/4.0/
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
dc.format.none.fl_str_mv application/pdf
105-106
dc.source.none.fl_str_mv reponame:SEDICI (UNLP)
instname:Universidad Nacional de La Plata
instacron:UNLP
reponame_str SEDICI (UNLP)
collection SEDICI (UNLP)
instname_str Universidad Nacional de La Plata
instacron_str UNLP
institution UNLP
repository.name.fl_str_mv SEDICI (UNLP) - Universidad Nacional de La Plata
repository.mail.fl_str_mv alira@sedici.unlp.edu.ar
_version_ 1844616174243938304
score 13.070432

Publicaciones similares